Yong Oh Lee is a notable inventor based in Koyang, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of metabolic bone diseases. With a total of 2 patents, his work focuses on innovative compositions that enhance therapeutic efficacy.

Latest Patents

Yong Oh Lee's latest patents include a pharmaceutical composition for the treatment of metabolic bone disease. This invention relates to a composite pharmaceutical agent that comprises calcitriol and alendronate as its main active ingredients. The composition is designed to reduce the rate of spine fractures and increase bone density. It effectively inhibits hypercalcemia caused by calcitriol alone and improves drug compliance.

Another significant patent involves a pharmaceutical composition comprising ticlopidine and Ginkgo biloba extract. This anti-thrombotic preparation utilizes the PAF-antagonistic and anti-oxidant actions of both components to suppress the adverse effects caused by the repeated use of ticlopidine.

Career Highlights

Throughout his career, Yong Oh Lee has worked with various companies, including Yuyu Industrial Co., Ltd. and Yuyu International Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Yong Oh Lee has collaborated with notable coworkers such as Sung An Kang and Kyung Hee Lee. Their joint efforts have further advanced the development of effective pharmaceutical compositions.

Conclusion

Yong Oh Lee's contributions to pharmaceutical innovations demonstrate his commitment to improving treatment options for metabolic bone diseases. His patents reflect a deep understanding of the complexities involved in drug formulation and patient care.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com